| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |